The IGF1 is a polypeptide that is mediated mitogenic and anti-apoptotic effects via IGF1 receptor that is a type 2 tyrosine kinase receptor, and the accumulating evidence indicated that IGF axis played pivotal roles in human cancer progression and can be targets for therapeutic intervention (36, 37). This evidence concerns the gene IGF1 and cancer.